Compound Information | SONAR Target prediction | Name: | EPIANDROSTANEDIOL | Unique Identifier: | SPE00107093 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C19H32O2 | Molecular Weight: | 261.21 g/mol | X log p: | -0.0960000000000001 (online calculus) | Lipinksi Failures | 0 | TPSA | 0 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 2 | Rotatable Bond Count: | 0 | Canonical Smiles: | CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O | Source: | ex numerous mammalian tissues | Therapeutics: | regulation of puberty in females | Generic_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | Chemical_iupac_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | Drug_type: | Experimental | Drugbank_id: | EXPT00530 | Logp: | 3.73 | Drug_category: | Sex Hormone-Binding Globulin inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
BCK1 |
Replicates: |
2 |
Raw OD Value: r im |
0.4801±0.00282843 |
Normalized OD Score: sc h |
0.7213±0.000999504 |
Z-Score: |
-5.4479±0.115872 |
p-Value: |
0.0000000562834 |
Z-Factor: |
0.632361 |
Fitness Defect: |
16.6929 |
Bioactivity Statement: |
Active |
Experimental Conditions | | Library: | Spectrum | Plate Number and Position: | 2|G7 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 24.50 Celcius | Date: | 2006-03-24 YYYY-MM-DD | Plate CH Control (+): | 0.038675±0.00123 | Plate DMSO Control (-): | 0.6602250000000001±0.02150 | Plate Z-Factor: | 0.9014 |
| png ps pdf |
15981575 |
(2S,3R,7R)-3,7-dimethyltridecan-2-ol |
16049918 |
(1S,4R)-5-deuterio-6-hydroxy-bicyclo[2.2.1]heptane |
16055632 |
(3S,4S,5S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methyl-heptan-2-yl]-4,10,13-trimethyl-2,3,4,5,6,7 ,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
16057425 |
[(1R,4R,5R)-1,7,7-trimethyl-5-bicyclo[2.2.1]heptyl]methanol |
16057429 |
(1R,3S,4S)-6,6-dimethylbicyclo[2.2.1]heptan-3-ol |
16057431 |
magnesium; decan-1-olate; propan-2-olate |
active | Cluster 12674 | Additional Members: 6 | Rows returned: 4 | |
|